New drug interaction study completed in 12 healthy volunteers
NCT ID NCT06846684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested whether a new drug called SB17170 changes how the body processes another drug, SB_MDZ. Twelve healthy adults took SB17170 by mouth and received SB_MDZ through an IV. Researchers measured drug levels in the blood to see if there is an interaction. The study is complete, but results are not yet available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SB17170 and SB_MDZ
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG DRUG INTERACTION (DDI) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, South Korea